BOA1

Featured post

#Assessment of #risk associated with #influenza A(#H5N8) virus, 17 November 2016 (@WHO)

  Title : #Assessment of #risk associated with #influenza A(#H5N8) virus, 17 November 2016. Subject : Avian Influenza, H5N8 subtype, multi...

11 Nov 2016

Weekly #US #Influenza #Surveillance #Report - 2016-17 Season, Wk 44 ending Nov. 5, 2016 (@CDCgov, Nov. 11 ‘16)

 

Title: Weekly #US #Influenza #Surveillance #Report - 2016-17 Season, Wk 44 ending Nov. 5, 2016.

Subject: Seasonal Influenza, weekly US CDC activity surveillance report.

Source: US Centers for Disease Control and Prevention (CDC), FluView, full page: (LINK). Summary.

Code: [     ]

_____

Weekly U.S. Influenza Surveillance Report - 2016-2017 Influenza Season Week 44 ending November 5, 2016

___

|-- Full report also available as PDF –|

All data are preliminary and may change as more reports are received.

 

Synopsis:

  • During week 44 (October 30-November 5, 2016), influenza activity was low in the United States.
    • Viral Surveillance:
      • The most frequently identified influenza virus subtype reported by public health laboratories during week 44 was influenza A (H3).
      • The percentage of respiratory specimens testing positive for influenza in clinical laboratories increased slightly but remained low.
    • Pneumonia and Influenza Mortality:
      • The proportion of deaths attributed to pneumonia and influenza (P&I) was below the system-specific epidemic threshold in the National Center for Health Statistics (NCHS) Mortality Surveillance System.
    • Influenza-associated Pediatric Deaths:
      • No influenza-associated pediatric deaths were reported.
    • Outpatient Illness Surveillance:
      • The proportion of outpatient visits for influenza-like illness (ILI) was 1.4%, which is below the national baseline of 2.2%.
      • All 10 regions reported ILI below region-specific baseline levels.
      • Puerto Rico experienced moderate ILI activity, one state experienced low ILI activity, New York City and 49 states experienced minimal ILI activity, and the District of Columbia had insufficient data.
    • Geographic Spread of Influenza:
      • The geographic spread of influenza in Guam, Puerto Rico, and one state was reported as regional; six states reported local activity; the District of Columbia, the U.S. Virgin Islands and 39 states reported sporadic activity; and four states reported no activity.

 

National and Regional Summary of Select Surveillance Components

[HHS Surveillance Regions* - Data for current week: Out-patient ILI† - Number of jurisdictions reporting regional or widespread activity§ - % respiratory specimens positive for flu in clinical laboratories‡  - Data cumulative since October 2, 2016 (week 40): A(H1N1)pdm09 - A (H3) - A (Subtyping not Performed)  - B Victoria lineage  - B Yamagata lineage - B lineage not performed - Pediatric Deaths]

Influenza test results from public health laboratories only

  • Nation – Normal - 3 of 54 - 2.2% – 36 – 267 – 17 – 6 – 10 – 15 – 0
    • Region 1 – Normal - 1 of 6 - 0.5% – 0 – 19 – 0 – 0 – 0 – 0 – 0
    • Region 2 – Normal - 1 of 4 - 0.9% – 0 – 8 – 0 – 1 – 0 – 2 – 0
    • Region 3 – Normal  - 0 of 6 - 0.3% – 3 – 11 – 1  - 0 – 1 – 0 – 0
    • Region 4 – Normal - 0 of 8 - 4.1% – 1 – 31 – 2 – 1 – 2 – 6 – 0
    • Region 5 – Normal - 0 of 6 - 0.8% – 1 – 34 – 7 – 1 – 1 – 1 – 0
    • Region 6 – Normal  - 0 of 5 - 1.3% – 3 – 3 – 0 – 2 – 5 – 0 – 0
    • Region 7 – Normal - 0 of 4 - 0.2% – 0 – 7 – 1 – 1 – 0 – 1 – 0
    • Region 8 – Normal - 0 of 6 - 1.1% – 23 – 31 – 0 – 0 – 0 – 0 – 0
    • Region 9 – Normal - 1 of 4 - 1.4% – 4 – 58 – 6 – 0 – 1 – 2 – 0
    • Region 10 – Normal - 0 of 4 - 4.2% – 1 – 65 – 0 – 0 – 0 – 3 – 0

___

{*} HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, US Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; and Region 10: AK, ID, OR, WA).

{†} Elevated means the % of visits for ILI is at or above the national or region-specific baseline

{§} Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and U.S. Virgin Islands

{‡} National data are for current week; regional data are for the most recent three weeks

 

U.S. Virologic Surveillance

WHO and NREVSS collaborating laboratories, which include both public health and clinical laboratories located in all 50 states, Puerto Rico, and the District of Columbia, report to CDC the total number of respiratory specimens tested for influenza and the number positive for influenza by virus type. In addition, public health laboratories also report the influenza A subtype (H1 or H3) and influenza B lineage information for the viruses they test and the age or age group of the persons from whom the specimens were collected.

Additional data are available at http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html and http://gis.cdc.gov/grasp/fluview/flu_by_age_virus.html.

____

The results of tests performed by clinical laboratories during the current week are summarized below.

[Week 44 - Data Cumulative since October 2, 2016 (Week 40)]

  • No. of specimens tested - 12,410 - 64,421
    • No. of positive specimens (%) - 268 (2.2%) - 1,060 (1.6%)
      • Positive specimens by type:
        • Influenza A - 163 (60.8%) - 626 (59.1%)
        • Influenza B - 105 (39.2%) - 434 (40.9%)

(…)

View National and Regional Level Graphs and Data

_____

The results of tests performed by public health laboratories, as well as the age group distribution of influenza positive tests, during the current week are summarized below.

[Week 44 - Data Cumulative since October 2, 2016 (Week 40)]

  • No. of specimens tested – 572 - 3,874
    • No. of positive specimens – 34 – 351
      • Positive specimens by type/subtype:
        • Influenza A - 31 (91.2%) - 320 (91.2%)
          • A(H1N1)pmd09 - 5 (16.1%) - 36 (11.3%)
          • H3 - 18 (58.1%) - 267 (83.4%)
          • Subtyping not performed - 8 (25.8%) - 17 (5.3%)
        • Influenza B - 3 (8.8%) - 31 (8.8%)
          • Yamagata lineage - 1 (33.3%) - 10 (32.3%)
          • Victoria lineage - 0 (0%) - 6 (19.4%)
          • Lineage not performed - 2 (66.7%) - 15 (48.4%)

(…)

View National and Regional Level Graphs and Data

(…)

-

Keywords: US CDC; USA; Updates; Seasonal Influenza.

-------